https://scholars.lib.ntu.edu.tw/handle/123456789/623263
標題: | Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis | 作者: | TUNG-HUNG SU Peng, Cheng-Yuan Chang, Shan-Han TAI-CHUNG TSENG CHUN-JEN LIU CHI-LING CHEN CHEN-HUA LIU HUNG-CHIH YANG PEI-JER CHEN JIA-HORNG KAO |
關鍵字: | AFP; DCP; Des-carboxyprothrombin; Liver cancer; Prothrombin induced by vitamin K Absence or antagonist-II | 公開日期: | 三月-2022 | 出版社: | ELSEVIER TAIWAN | 卷: | 121 | 期: | 3 | 起(迄)頁: | 703 | 來源出版物: | Journal of the Formosan Medical Association = Taiwan yi zhi | 摘要: | The risk of hepatocellular carcinoma (HCC) is reduced but not eliminated after nucleos(t)ide analogue (NA) therapy in chronic hepatitis B (CHB). We aimed to investigate the role of serum Prothrombin Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) and alpha-fetoprotein in predicting HCC and mortality in cirrhotic CHB patients at virological remission (VR) following NA therapy. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/623263 | ISSN: | 0929-6646 | DOI: | 10.1016/j.jfma.2021.08.003 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。